14-3-3 σ and checkpoint with forkhead and ring finger (CHFR) methylation in serum in erlotinib-treated non-small-cell lung cancer (NSCLC) patients (p) with EGFR mutations

被引：0
|
作者：
Reguart, N.
Porta, R.
Provencio, M.
Cardenal, F.
Cuello, M.
Ramirez, J. L.
Mayo, C.
Lianes, P.
Taron, M.
Rosell, R.
机构：
[1] Hosp Badalona Germans Trias & Pujol, ICO, Badalona, Spain
[2] Hosp Josep Trueta, ICO, Girona, Spain
[3] Clin Puerta del Hierro, Madrid, Spain
[4] Hosp Duran & Reynals, ICO, Barcelona, Spain
[5] Hosp Mataro, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7600
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (pts)
    Moran, T.
    Salazar, F.
    Cobo, M.
    Isla, D.
    Massuti, B.
    Montes, A.
    Provencio, M.
    Vinolas, N.
    Paz-Ares, L.
    Rosell, R.
    LUNG CANCER, 2006, 52 : S26 - S26
  • [42] Wood-Smoke Exposure (WSE) as a Predictor of Response and Survival in Erlotinib-Treated Non-small Cell Lung Cancer (NSCLC) Patients
    Cardona, Andres Felipe
    Reguart, Noemi
    Reveiz, Ludovic
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 142 - 143
  • [43] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [44] The presence of EGFR mutations predicts the response in Chinese non-small cell lung cancer patients treated with erlotinib
    Li, Rui-chao
    Zheng, Li-jun
    Fang, Ming-hao
    Yu, Shi-ying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (02): : E112 - E119
  • [45] RETROSPECTIVE EFFICACY AND SAFETY ANALYSIS OF ERLOTINIB (E), PEMETREXED (P) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER PATIENTS (NSCLC) WITHOUT EGFR MUTATION
    Takeshita, J.
    Katakami, N.
    Nishiyama, A.
    Yoshioka, H.
    Iwasaku, M.
    Hata, A.
    Imamura, F.
    Nishino, K.
    Yokota, S.
    Morita, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 437 - 437
  • [46] Skin toxicity associated with outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations in the EURTAC study.
    Buges, Cristina
    Marti, Alex Martinez
    Rosell, Rafael
    Vergnenegre, Alain
    De Marinis, Filippo
    Massuti, Bartomeu
    De Castro, Javier
    Gervais, Radj
    Costa, Enric Carcereny
    Moran, Teresa
    Santarpia, Mariacarmela
    Felip, Enriqueta
    Majem, Margarita
    Porta, Rut
    Palmero, Ramon
    Drozdowskyj, Ana
    Heidecke, Cordula
    Gasco, Amaya
    Taron, Miquel
    Paz-Ares, Luis G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Correlation between BRCA1 and LMO4 mRNA expression levels in Erlotinib-treated non small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Costa, Carlota
    Gimenez-Capitan, Ana
    Benlloch, Susana
    Taron, Miguel
    Jimeno, Jose
    Viteri, Santiago
    Gasco, Amaya
    Camps, Carlos
    Carcereny, Enric
    Massuti, Bartomeu
    Rosell, Rafael
    CANCER RESEARCH, 2012, 72
  • [48] VARIABILITY OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN SERUM DURING ERLOTINIB THERAPY AND ITS CLINICAL IMPLICATIONS: EXPLORATORY ANALYSIS OF A PHASE II STUDY OF ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING EGFR MUTATIONS
    Maemondo, Makoto
    Nishio, Makoto
    Yamamoto, Noboru
    Chikamori, Kenichi
    Katakami, Nobuyuki
    Hida, Toyoaki
    Seto, Takashi
    Yoshioka, Hiroshige
    Kozuki, Toshiyuki
    Ohishi, Norihisa
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S384 - S385
  • [49] sLAG-3 in non-small-cell lung cancer patients' serum
    He, Yayi
    Wang, Yan
    Zhao, Sha
    Zhao, Chao
    Zhou, Caicun
    Hirsch, Fred R.
    ONCOTARGETS AND THERAPY, 2018, 11 : 4781 - 4784
  • [50] Final analysis of erlotinib monotherapy for elderly patients with non-small-cell lung cancer harboring activating EGFR mutations.
    Akiyama, Norimichi
    Inoue, Yusuke
    Inui, Naoki
    Asada, Kazuhiro
    Karayama, Masato
    Matsuda, Hiroyuki
    Yokomura, Koshi
    Koshimizu, Naoki
    Imokawa, Shiro
    Yamada, Takashi
    Shirai, Toshihiro
    Kasamatsu, Norio
    Suda, Takafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345